INTERNATIONAL PATENT: ORIC PHARMACEUTICALS, INC. FILES APPLICATION FOR "INHIBITORS OF POLO-LIKE KINASE 4 (PLK4) FOR THE TREATMENT OF CANCER"

GENEVA, Oct. 6 -- ORIC PHARMACEUTICALS, INC. (240 E. Grand Avenue, 2nd FloorSouth San Francisco, California 94080) filed a patent application (PCT/US2025/021121) for "INHIBITORS OF POLO-LIKE KINASE 4 (PLK4) FOR THE TREATMENT OF CANCER" on Mar 24, 2025. With publication no. WO/2025/207503, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): EDGAR, Kyle Andrew (240 E. Grand Avenue, 2nd FloorSouth San Francisco, California 94080), JUNTTILA, Melissa R. (240 E. Grand Avenue, 2nd FloorSouth San Francisco, California 94080)

Abstrac...